Source: https://www.federalregister.gov/documents/2013/03/15/2013-06030/institutional-review-boards-correcting-amendments
Timestamp: 2017-08-16 19:38:58
Document Index: 795066532

Matched Legal Cases: ['art 56', 'art 56', 'art 56', 'art 56', '§\u200956', '§\u200956', '§\u200956']

Federal Register :: Institutional Review Boards; Correcting Amendments
Institutional Review Boards; Correcting Amendments
A Rule by the Food and Drug Administration on 03/15/2013
This final rule is effective March 15, 2013.
16401 (1 page)
Docket No. FDA-2013-N-0003
2013-06030
FDA-2013-N-0003
List of Subjects in 21 CFR Part 56
https://www.federalregister.gov/d/2013-06030 https://www.federalregister.gov/d/2013-06030
The Food and Drug Administration (FDA) is amending its regulations regarding institutional review boards to address a minor correction to the regulatory text and to update contact information. This action is editorial in nature and is intended to provide accuracy and clarity to the Agency's regulations.
Kathleen Pfaender, Office of Special Medical Programs, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, Rm. 5172, Silver Spring, MD 20993, 301-796-8346.
FDA is amending 21 CFR part 56 to correct a minor error in the Code of Federal Regulations (CFR), and to update obsolete information. A minor spelling error was introduced inadvertently in the CFR when the regulations were first published. Also, contact information in the regulations is obsolete and in need of updating.
Publication of this document constitutes final action under the Administrative Procedures Act (5 U.S.C. 553). FDA has determined that notice and public comment are unnecessary because this amendment to the regulations provides only technical changes to correct minor errors and to update obsolete information, and is nonsubstantive.
Reporting and reporting requirements, and Safety
Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs, 21 CFR part 56 is amended as follows:
1. The authority citation for 21 CFR part 56 continues to read as follows:
Authority: 21 U.S.C. 321, 343, 346, 346a, 348, 350a, 350b, 351, 352, 353, 355, 360, 360c-360f, 360h-360j, 371, 379e, 381; 42 U.S.C. 216, 241, 262, 263b-263n.
2. In § 56.106 revise paragraph (d) to read as follows:
§ 56.106
(d) Where can an IRB register? Each IRB may register electronically through http://ohrp.cit.nih.gov/​efile. If an IRB lacks the ability to register electronically, it must send its registration information, in writing, to the Office of Good Clinical Practice, Office of Special Medical Programs, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, Rm. 5129, Silver Spring, MD 20993.
3. Section 56.107 is amended in paragraph (a), by revising the 3rd sentence to read as follows:
§ 56.107
(a) * * * In addition to possessing the professional competence necessary to review the specific research activities, the IRB shall be able to ascertain the acceptability of proposed research in terms of institutional commitments and regulations, applicable law, and standards of professional conduct and practice. * * *
[FR Doc. 2013-06030 Filed 3-14-13; 8:45 am]